Company: GCTS
Filing Date: 2025-04-23
Form Type: S-3
Source: 0001104659-25-038103
Chunk: 20

Company: GCT Semiconductor Holding, Inc.
Filing Date: 2025-04-23
Form: S-3
Chunk 20
---
 includes this prospectus and exercise the usual standards of “due diligence” with respect thereto. B. Riley                                                                                                                                                                                                                                                                                                                                        
 Principal Capital II has agreed to pay Seaport a cash fee of $50,000 upon the completion of this offering as consideration for its services                                                                                                                                                                                                                                                                                                                       
 and to reimburse Seaport up to $5,000 for expenses incurred in connection with acting as the qualified independent underwriter in this                                                                                                                                                                                                                                                                                                                            
 offering. In accordance with FINRA Rule 5110, such cash fee and expense reimbursement to be paid to Seaport for acting as the qualified                                                                                                                                                                                                                                                                                                                           
 independent underwriter in this offering are deemed to be underwriting compensation in connection with sales of our Common Stock by B.                                                                                                                                                                                                                                                                                                                            
 Riley Principal Capital II to the public.                                                                                                                                                                                                                                                                                                                                                                                                                         
 In accordance with FINRA Rule 5121, BRS is not permitted                                                                                                                                                                                                                                                                                                                                                                                                          
 to sell shares of our Common Stock in this offering to an account over which it exercises discretionary authority without the prior specific                                                                                                                                                                                                                                                                                                                      
 written approval of the account holder. See “Plan of Distribution (Conflict of Interest).”                                                                                                                                                                                                                                                                                                                                                                        |
| Risk Factors                                                                                                          |     | Investing in our Common Stock involves a high degree of risk. See the section titled “Risk Factors” of this prospectus and the section titled “Risk Factors” in the documents incorporated by reference herein for a discussion of factors you should carefully consider before investing in our Common Stock.                                                                                                                                                    |
| NYSE Ticker-Symbol                                                                                                    |     | Common Stock: “GCTS”                                                                                                                                                                                                                                                                                                                                                                                                                                              
 Warrants: “GCTSW”                                                                                                                                                                                                                                                                                                                                                                                                                                                 |

| 9 |

<div align='center'>RISK FACTORS</div>

Investing in our Common Stock
involves substantial risk. You should carefully consider the risk factors disclosed below as well as those contained in our most recent
Annual Report on Form 10-K, which is incorporated by reference herein, as updated by our subsequent filings under the Exchange Act,
and the other information contained in this prospectus before acquiring any of our common stock. These risks could have a material adverse
effect on our business, results of operations or financial condition and cause the value of our common stock to decline. You could lose
all or part of your investment.

This prospectus also contains
or incorporates by reference forward-looking statements that involve risks and uncertainties. Our actual results could differ materially
from those anticipated in the forward-looking statements as a result of certain factors, including the risks